Insulin Icodec Showed Comparable Efficacy and Safety- KN95 หน้ากากป้องกันเครื่องช่วยหายใจ - การรับรอง CE American Heart Association ,This material is intended for global medical media only, excl US For journalistic assessment and preparation before publication. Today, Novo Nordisk announced results from a phase 2 clinical trial of investigational insulin icodec, a once-weekly basal insulin analogue.Insulin Icodec Showed Comparable Efficacy and SafetyIn the trial, adults with type 2 diabetes randomised to once-weekly insulin icodec achieved similar blood sugar control and a similar safety profile compared with adults with type 2 diabetes randomised to once-daily insulin glargine U100. Results were presented during the 80th Scientific Sessions of the American Diabetes Association.1



BlogGang.com : : The Imaginary Girl*

Symposium at the 55th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, Spain; 16-20 September 2019. 2. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384-95. 3.

แชทออนไลน์

WhatsApp

BlogGang.com : : The Imaginary Girl*

Symposium at the 55th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, Spain; 16-20 September 2019. 2. Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384-95. 3.

แชทออนไลน์

WhatsApp

Copyright ©AoGrand All rights reserved